Ulthera, Inc. is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy – the procedure enabled by the System – is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.